skip to content

Cambridge Stem Cell Institute

 
Read more at: New stem cell research funded as part of UK-Japan collaborations to tackle global challenges
New stem cell research funded as part of UK-Japan collaborations to tackle global challenges

New stem cell research funded as part of UK-Japan collaborations to tackle global challenges

7 August 2019

Professor Austin Smith from the Wellcome – MRC Cambridge Stem Cell Institute is one of the first round of researchers from the UK and Japan funded to tackle major global challenges in collaborative projects announced today, Friday 9th August 2019.


Read more at: New stem cell combination could help to repair damaged hearts
New stem cell combination could help to repair damaged hearts

New stem cell combination could help to repair damaged hearts

5 August 2019

A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research part-funded by the British Heart Foundation (BHF) and published in Nature Biotechnology.


Read more at: New study pinpoints cell types affected in brains of multiple sclerosis patients
New study pinpoints cell types affected in brains of multiple sclerosis patients

New study pinpoints cell types affected in brains of multiple sclerosis patients

17 July 2019

Scientists have discovered that a specific brain cell known as a ‘projection neuron’ has a central role to play in the brain changes seen in multiple sclerosis (MS).


Read more at: Pilkington Teaching Prize awarded to Prof Anna Philpott
Pilkington Teaching Prize awarded to Prof Anna Philpott

Pilkington Teaching Prize awarded to Prof Anna Philpott

26 June 2019

In a ceremony held yesterday evening (25th June) at Girton College, Professor Anna Philpott received one of this year’s Pilkington Prizes for teaching excellence at the University of Cambridge.


Read more at: New charity - Myelopathy.org - launched
New charity - Myelopathy.org - launched

New charity - Myelopathy.org - launched

17 May 2019

To raise awareness of myelopathy and to address gaps in our knowledge of the condition and how best to treat it, Cambridge Stem Cell Institute Affiliate, Dr Mark Kotter and colleague Ben Davies, together with Iwan Sadler, have launched Myelopathy.org, a charity that aims to give patients a voice and effect change.


Read more at: Establishing the Molecular Blueprint of Early Embryo Development
Establishing the Molecular Blueprint of Early Embryo Development

Establishing the Molecular Blueprint of Early Embryo Development

20 February 2019

A pioneering group of biologists, physicists and mathematical modellers in Cambridge have studied the genetic activity of over 100,000 embryonic cells to establish the molecular blueprint of mouse early embryo development.


Read more at: Stem Cell Research Hits the Road

Stem Cell Research Hits the Road

29 January 2019

Two PhD students from the Wellcome – MRC Cambridge Stem Cell Institute are embarking on a 6000km journey in a customised Renault 4L to support children and schools in Morocco, and to raise awareness of stem cell research at a global scale.


Read more at: From eye drops to potential leukaemia treatment
From eye drops to potential leukaemia treatment

From eye drops to potential leukaemia treatment

19 December 2018

An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer.


Read more at: Robin Franklin featured in iNews
Robin Franklin featured in iNews

Robin Franklin featured in iNews

7 December 2018

Prof Robin Franklin has been featured in an article published in iNews , where he talks about Multiple Sclerosis research and how vital it is to increase the funding available to study the disease. Robin is a senior scientist at the Cambridge Stem Cell Institute and Director of the Cambridge MS Society Centre for Myelin...


Read more at: Genetics allows personalised disease predictions for chronic blood cancers
Genetics allows personalised disease predictions for chronic blood cancers

Genetics allows personalised disease predictions for chronic blood cancers

10 October 2018

Scientists have developed a successful method to make truly personalised predictions of future disease outcomes for patients with certain types of chronic blood cancers. The study from the Wellcome Sanger Institute, the Wellcome-MRC Cambridge Stem Cell Institute, the University of Cambridge, and their collaborators...